London: U.S. Food and Drug Administration said on friday Merit Medical Systems has begun recalling unapproved plastic syringes supplied by China-based Jiangsu Shenli Medical Production.

The FDA recommended against the use of certain syringes coming from China in 2023 as it investigated reports of leaks, breakages and other problems. Quality problems with such products.

Merit said it was taking steps to immediately get rid of Jiangsu Shenli syringes, and urged anyone else to stop using or distributing them. Products containing Affected syringes.

In March, the FDA also issued warning letters. Medline Industries And Sol-Millennium Medical Violations related to the sale and distribution of unauthorized plastic syringes manufactured in China in collaboration with Jiangsu Shenli were described.

Jiangsu Shenli began the recall of its unauthorized plastic syringes in May, the regulator said.

Cardinal Health The company was also sent a warning letter in April after an inspection at its Illinois plant found that it was illegally marketing and distributing the substance. Unapproved syringes Created by Jiangsu Shenli.

The regulator said it would continue efforts to evaluate problems linked to syringes manufactured in China. (Reporting by Puyan Singh in Bengaluru; Editing by Vijay Kishor)